What is the clinical evidence from this study?

Study design: Cross-Sectional. Population: Hypertension (n=341). Intervention: General Medication Adherence Scale. Primary outcome: Quality of life score measured by WHOQOL-BREF (p=<0.05).

What type of study is this?

This is a Cross-Sectional Study study.

What does this research mean for the field?

Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

This research aims to evaluate medication adherence levels in hypertensive patients and its effect on their quality of life.

January 9, 2026Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi DergisiOpen Access

Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients.

Q: What are the key findings of this study?

Q: What type of study is this?

This is a Cross-Sectional Study study.

Q: What does this research mean for the field?

Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

Q: What question did this study set out to answer?

This research aims to evaluate medication adherence levels in hypertensive patients and its effect on their quality of life.

View Full Paper

Ask AI

Bookmark

Key result

Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients.

Authors

BYBirol Yetim

Discussion

Member takes

Overview

Cross-sectional analysis examines medication adherence and its impact on quality of life in hypertensive patients, indicating significant associations.

Key Points

This research aims to evaluate medication adherence levels in hypertensive patients and its effect on their quality of life.
Cross-sectional study conducted with 341 hypertensive patients
Data collected using demographic forms, General Medication Adherence Scale, and WHOQOL-BREF
Utilized descriptive statistics, t-tests, ANOVA, and multiple regression analysis
Medication adherence level averaged 1.86
Quality of life score was 43.62 out of 100
Lowest scores in quality of life were in the physical health domain
Medication adherence varied significantly with age, education, income, disease duration, and comorbidities

Study Design

Type

Cross-Sectional (n=341)

Multicenter

PICO

Population

Hypertension (n=341)

Intervention / Comparator

General Medication Adherence Scale

Primary Outcome

Quality of life score measured by WHOQOL-BREF, p=<0.05

Main Result

p-value: p=<0.05

Limitations

Study is based on self-reported data which may introduce bias
Findings may not be generalizable as data was collected from a single center

Cite This Study

Birol Yetim (2025) conducted a cross-sectional in Hypertension (n=341). General Medication Adherence Scale was evaluated on Quality of life score measured by WHOQOL-BREF (p=<0.05). Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients.

synapsesocial.com/papers/69612fdc30ef6c21f6853df4 https://doi.org/10.21020/husbfd.1715486

View Full Paper

Ask AI

Bookmark

January 9, 2026Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi DergisiOpen Access

Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients.

View Full Paper

Ask AI

Bookmark

Key result

Higher levels of medication adherence significantly enhance the quality of life in hypertensive patients.

Authors

BYBirol Yetim

Discussion

Member takes

Overview

Cross-sectional analysis examines medication adherence and its impact on quality of life in hypertensive patients, indicating significant associations.

Key Points

This research aims to evaluate medication adherence levels in hypertensive patients and its effect on their quality of life.
Cross-sectional study conducted with 341 hypertensive patients
Data collected using demographic forms, General Medication Adherence Scale, and WHOQOL-BREF
Utilized descriptive statistics, t-tests, ANOVA, and multiple regression analysis
Medication adherence level averaged 1.86
Quality of life score was 43.62 out of 100
Lowest scores in quality of life were in the physical health domain
Medication adherence varied significantly with age, education, income, disease duration, and comorbidities

Study Design

Type

Cross-Sectional (n=341)

Multicenter

PICO

Population

Hypertension (n=341)

Intervention / Comparator

General Medication Adherence Scale

Primary Outcome

Quality of life score measured by WHOQOL-BREF, p=<0.05

Main Result

p-value: p=<0.05

Limitations

Study is based on self-reported data which may introduce bias
Findings may not be generalizable as data was collected from a single center

Cite This Study

synapsesocial.com/papers/69612fdc30ef6c21f6853df4 https://doi.org/10.21020/husbfd.1715486

View Full Paper

Ask AI

Bookmark